Last reviewed · How we verify
NCT03825263: IMPRESS
Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema
NA trial testing Intermittent Pressure Compression in Lymphoedema in 20 participants. Completed in 28 February 2018.
17 January 2018
Quick facts
| Lead sponsor | University of South Wales |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 10 May 2017 |
| Primary completion | 17 January 2018 |
| Estimated completion | 28 February 2018 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Intermittent Pressure Compression
Conditions studied
- Lymphoedema — all drugs for Lymphoedema →
Sponsor
University of South Wales
Who can join
18 and older, any sex, with Lymphoedema. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The treatment of lymphoedema and its associated complications represent a considerable drain on increasingly limited NHS resources. Intermittent pneumatic compression, specifically the LymphAssist (Huntleigh Healthcare), represents an innovative treatment for this condition but the efficacy of this device needs to be investigated via robust clinical research.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Home management of lower limb lymphoedema with an intermittent pneumatic compression device: a feasibility study.
Dunn N, Williams EM, Fishbourne M, Dolan G, et al · · 2019 · cited 5× · PMID 31583112 · DOI 10.1186/s40814-019-0496-4
Verify or expand the search:
- PubMed search for NCT03825263
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lymphoedema
Currently open trials in the same condition.
- NCT07011316 — Subclinical Monitoring of Lymphatic Function in Oncology Patients for Lymphoedema Prevention (ONCOLYMPH) · recruiting
Other University of South Wales trials
Trials by the same sponsor.
- NCT06981130 — ASPIRE II. Supporting Antibiotic Stewardship in Primary Care Via POCT · NA · completed
- NCT06912022 — ASPIRE I: Supporting Antibiotic Stewardship in Primary Care Via POCT · completed
- NCT05109260 — Destiny: D-dimer. Investigating D-dimer Levels Using Point-of-Care (POC) Testing at Primary Care. · unknown
- NCT05603234 — Symptom Monitoring and Menopausal Symptoms · NA · completed
- NCT04099095 — A Mental Health Social Prescribing Trial (British Red Cross) · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03825263 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of South Wales
- Last refreshed: 31 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03825263.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing